Project Details
Description
Efficacy and safety of Ezetimibe/Simvastatin and Niacin co-administered in Patients with Type IIa or Type IIb Hyperlipidemia.
| Status | Finished |
|---|---|
| Effective start/end date | 11/9/05 → 11/8/08 |
Funding
- MERCK AND CO INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.